Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Apigenin suppresses ovarian cancer cell growth by disrupting TGF-beta1-mediated cancer–stroma interaction via AKT inhibition

Related

  1. The EMA Qualification Opinion for CYP Inhibition‐Mediated Drug–Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15
    Karen Rowland Yeo, Sibylle Neuhoff, Oliver Hatley +4
    Clinical Pharmacology and TherapeuticsPeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMC
  2. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway [Retraction].
    Cancer management and researchPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  3. Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
    Sijing Chen, Yunyang Zhao, Yunqi Pan +13
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Metformin promotes apoptosis of senescent chondrocytes by disrupting the Bcl-xL/Mcl-1–Bak interaction
    Biying Feng, Longzhou Liu, Yueyang Lin +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  5. PARG inhibition suppresses osteoclast differentiation through transcriptional activation of an NRF2-dependent pathway
    Yuka Sasaki, Ryusuke Nakatsuka, Ryoji Taniguchi +3
    PLOS OnePeer-reviewedCC BY 4.0Full textPhysiologyPLOS
BibTeX
@article{kwon2026apigenin,
  title = {{Apigenin suppresses ovarian cancer cell growth by disrupting TGF-beta1-mediated cancer–stroma interaction via AKT inhibition}},
  author = {Youngjoo Kwon and Somin Lee and Hyunjin Seo and Soo-Jung Lee},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-77491-9},
  url = {https://www.nature.com/articles/s41598-026-77491-9},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Apigenin suppresses ovarian cancer cell growth by disrupting TGF-beta1-mediated cancer–stroma interaction via AKT inhibition
AU  - Youngjoo Kwon
AU  - Somin Lee
AU  - Hyunjin Seo
AU  - Soo-Jung Lee
PY  - 2026
DA  - 2026/10/28
JO  - Scientific Reports
DO  - 10.1038/s41598-026-77491-9
UR  - https://www.nature.com/articles/s41598-026-77491-9
SN  - 2045-2322
ER  -